 |
Corporate News
23-Aug-23
|
|
|
|
|
|
|
|
|
|
|
|
J B Chemicals & Pharmaceuticals receives USFDA approval for Doxepin Hydrochloride capsules
|
|
|
|
|
|
|
|
J B Chemicals & Pharmaceuticals has received USFDA approval for Abbreviated New Drug Application (ANDA) for Doxepin Hydrochloride Capsules USP, 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, the generic version of Sinequan (Pfizer), which is indicated for the treatment of anxiety, depression, and other target symptoms of psychoneurosis.
The drug will be manufactured at the company's manufacturing facility at Panoli, Gujarat.
Doxepin Hydrochloride Capsules had an estimated annual sales of
US $23.90 million in the United States (IQVIA MAT Jun' 2023).
|
|
|
|
Previous News |
J B Chemicals & Pharmaceuticals consolidated net profit rises 43.97% in the March 2024 quarter
(
Results
-
Announcements
18-May-24
09:31
)
|
|
|
J B Chemicals & Pharmaceuticals allots 78,440 equity shares under ESOS
(
Corporate News
-
07-Nov-23
18:14
)
|
|
|
J B Chemicals & Pharmaceuticals allots 43,450 equity shares under ESOS
(
Corporate News
-
05-Mar-24
18:45
)
|
|
|
J B Chemicals & Pharmaceuticals appoints director
(
Corporate News
-
07-Nov-23
18:13
)
|
|
|
J B Chemicals & Pharmaceuticals to announce Quarterly Result
(
Corporate News
-
31-Oct-23
14:18
)
|
|
|
J B Chemicals & Pharmaceuticals appoints CFO
(
Corporate News
-
06-Feb-24
18:53
)
|
|
|
J.B.Chemicals Gujarat facilty clears USFDA inspection
(
Hot Pursuit
-
12-Jun-23
13:26
)
|
|
|
JB Pharma jumps on USFDA nod for anxiety drug
(
Hot Pursuit
-
23-Aug-23
12:57
)
|
|
|
Board of J B Chemicals & Pharmaceuticals recommends final dividend
(
Corporate News
-
18-May-24
09:31
)
|
|
|
J B Chemicals & Pharmaceuticals' Panoli unit clears USFDA inspection
(
Corporate News
-
12-Jun-23
13:03
)
|
|
|
J B Chemicals & Pharmaceuticals grants 83,497 stock options
(
Corporate News
-
09-Aug-23
18:17
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|